Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12419948 | Immunogenic compositions and use thereof | Pardis Sabeti, Shira Weingarten-Gabbay, Susan Klaeger, Jenn Abelin, Mohsan Saeed +3 more | 2025-09-23 |
| 12421557 | Methods for predicting outcomes and treating colorectal cancer using a cell atlas | Aviv Regev, Vijay K. Kuchroo, Ana Carrizosa Anderson, Orit Rozenblatt-Rosen, Jonathan Chen +2 more | 2025-09-23 |
| 12394502 | Method for predicting HLA-binding peptides using protein structural features | Catherine J. Wu, Siranush Sarkizova, Matthew Bakalar | 2025-08-19 |
| 12226479 | Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof | Moshe Sade-Feldman, Keren Yizhak, Gad Getz | 2025-02-18 |
| 12188925 | Multi-stage, multiplexed target isolation and processing from heterogeneous populations | Paul Blainey, Dwayne Vickers | 2025-01-07 |
| 11965892 | HLA-based methods and compositions and uses thereof | Jennifer Grace Abelin, Rob C. Oslund, Dominik Barthelme, Michael Steven Rooney | 2024-04-23 |
| 11939637 | Molecular biomarkers for cancer immunotherapy | Michael Steven Rooney | 2024-03-26 |
| 11766446 | Treatment of aging-associated conditions by DNA degradation | Yuk Yuen Lan | 2023-09-26 |
| 11650211 | HLA-based methods and compositions and uses thereof | Jennifer Grace Abelin, Rob C. Oslund, Dominik Barthelme, Michael Steven Rooney | 2023-05-16 |
| 11634777 | Resistance to checkpoint blockade therapy | Moshe Sade-Feldman | 2023-04-25 |
| 11630103 | Product and methods useful for modulating and evaluating immune responses | Alexandra-Chloé Villani, Rahul Satija, Aviv Regev | 2023-04-18 |
| 11597934 | Methods and compositions for reducing immunosuppression by tumor cells | Kai W. Wucherpfennig, Glenn Dranoff, Penghui Zhou, Donald Shaffer, Harvey Cantor +1 more | 2023-03-07 |
| 11452768 | Combination therapy with neoantigen vaccine | Catherine J. Wu, Edward F. Fritsch | 2022-09-27 |
| 11197467 | Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes | Aviv Regev, Oren Parnas, Marko Jovanovic, Thomas Eisenhaure | 2021-12-14 |
| 10993997 | Methods for profiling the t cell repertoire | Catherine J. Wu, Edward F. Fritsch, Ute E. Burkhardt | 2021-05-04 |
| 10975442 | Molecular biomarkers for cancer immunotherapy | Michael Steven Rooney | 2021-04-13 |
| 10962527 | Multi-stage, multiplexed target isolation and processing from heterogeneous populations | Paul Blainey, Dwayne Vickers | 2021-03-30 |
| 10876120 | Methods and compositions for reducing immunosupression by tumor cells | Kai W. Wucherpfennig, Glenn Dranoff, Penghui Zhou, Donald Shaffer, Harvey Cantor +1 more | 2020-12-29 |
| 10835585 | Shared neoantigens | Edward F. Fritsch, Michael Steven Rooney, Sachet Ashok Shukla, Catherine J. Wu, Pavan Bachireddy +1 more | 2020-11-17 |
| 10426824 | Compositions and methods of identifying tumor specific neoantigens | Catherine J. Wu | 2019-10-01 |
| 9944931 | Methods and compositions for reducing immunosupression by tumor cells | Kai W. Wucherpfennig, Glenn Dranoff, Penghui Zhou, Donald Shaffer, Harvey Cantor +1 more | 2018-04-17 |
| 9901631 | Method and cells for the production of viral vaccines | Marciela Degrace, Sagi Shapira, Liguo Wu | 2018-02-27 |
| 9814741 | Methods relating to DNA-sensing pathway related conditions | Mark LEE | 2017-11-14 |
| 9625444 | Artificial immune system: methods of use | William L. Warren, Heather Fahlenkamp, Russell Higbee, Anatoly Kachurin, Conan Li +6 more | 2017-04-18 |
| 9115402 | Compositions and methods of identifying tumor specific neoantigens | Catherine J. Wu | 2015-08-25 |